The Future of Companion Diagnostics - Digital Biomarkers

The integration of digital technologies into healthcare has opened up new avenues for personalised medicine and patient-centred care. Companion diagnostics can revolutionise disease diagnosis, monitoring, and treatment.

Digital biomarkers enhance clinical trial design and drug development processes; so much so that with real-world data from a diverse patient population, researchers can gain a deeper understanding of how treatments work in different contexts leading to more targeted interventions and improved patient outcomes. 

However, as with any emerging technology, challenges need to be addressed. The validation and standardisation of digital biomarkers are crucial to ensure their reliability and reproducibility across different devices and platforms. 

Join your peers to discuss how we can collectively advance the field of digital biomarkers: 

• How can we address the key challenges of integrating digital biomarkers as diagnostic tools into clinical practice for widespread adoption and accurate diagnosis? 
• How can we effectively communicate the benefits of digital biomarkers to patients, providers, and other healthcare stakeholders, ensuring they are understood and embraced within the ecosystem? 
• What are the future research directions and areas of innovation in the field of digital biomarkers? 
  
  

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.